These benefits, along with a past report demonstrating that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 guidance the notion of focusing on ACKR3 as a singular method to modulate the opioid system, which could open up new therapeutic avenues for opioid-relate